Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XH-02 in Adult Hypoparathyroidism
NCT07540286Phase 2Suspended
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of XH-02 in hypoparathyroidism, sponsored by Peking Union Medical College Hospital. Started Apr 2026; status: suspended.
02
Drugs
XH-02
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT07540286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540286.